JAK2 and neoplasm: When analyzing genetic pathways for the five patients with both primary and recurrent tumor pathology, two of the most significantly altered pathways included cardiac β‐adrenergic signaling (Z score = −0.378; p = 0.0455) and the role of JAK2 in hormone‐like cytokine signaling (p = 0.0496) (Figure 5D).